Holst VA, Junkins-Hopkins JM, Elenitsas R. Cutaneous smooth muscle neoplasms: clinical features, histologic findings, and treatment options. J Am Acad Dermatol. 2002 Apr. 46(4):477-90; quiz, 491-4. [QxMD MEDLINE Link].
Gokdemir G, Sakiz D, Koslu A. Multiple cutaneous leiomyomas of the nipple. J Eur Acad Dermatol Venereol. 2006 Apr. 20(4):468-9. [QxMD MEDLINE Link].
Brooks JK, Nikitakis NG, Goodman NJ, Levy BA. Clinicopathologic characterization of oral angioleiomyomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Aug. 94(2):221-7. [QxMD MEDLINE Link].
Nagata S, Nishimura H, Uchida M, Hayabuchi N, Zenmyou M, Fukahori S. Giant angioleiomyoma in extremity: report of two cases. Magn Reson Med Sci. 2006 Jul. 5(2):113-8. [QxMD MEDLINE Link].
Yagi K, Hamada Y, Yasui N. A leiomyoma arising from the deep palmar arterial arch. J Hand Surg [Br]. Dec 2006. 31(6):680-2. [QxMD MEDLINE Link].
Zaballos P, Del Pozo LJ, Argenziano G, Medina C, Lacarrubba F, Ferrer B, et al. Dermoscopy of cutaneous smooth muscle neoplasms: a morphological study of 136 cases. J Eur Acad Dermatol Venereol. 2019 Apr. 33 (4):693-699. [QxMD MEDLINE Link].
Naguib NN, Nour-Eldin NE, Serag Eldin F, Mazloum YZ, Agameya AF, Abou Seif S, et al. Uterine Artery Embolization for Uterine Leiomyoma: Role of Uterine Artery Doppler in the Pre-Interventional, Interventional and Post-interventional Patient Workup. Ultrasound Obstet Gynecol. 2011 Dec 16. [QxMD MEDLINE Link].
Virchow R. Ueber Makroglossie und pathologische Neubildung quergestreifter Muskelfasern. Virchows Arch (Pathol Anat). 1854. 7:126-38.
Kloepfer HW, Krafchuk J, Derbes V. Hereditary multiple leiomyoma of the skin. Am J Hum Genet. 1958 Mar. 10(1):48-52. [QxMD MEDLINE Link].
Utikal J, Haus G, Poenitz N, Koenen W, Back W, Dippel E. Cutaneous leiomyosarcoma with myxoid alteration arising in a setting of multiple cutaneous smooth muscle neoplasms. J Cutan Pathol. 2006 Sep. 33 Suppl 2:20-3. [QxMD MEDLINE Link].
Nishio J, Iwasaki H, Ohjimi Y, Ishiguro M, Kobayashi K, Nabeshima K, et al. Chromosomal imbalances in angioleiomyomas by comparative genomic hybridization. Int J Mol Med. 2004 Jan. 13 (1):13-6. [QxMD MEDLINE Link].
Horton E, Dobin SM, Debiec-Rychter M, Donner LR. A clonal translocation (7;8)(p13;q11.2) in a leiomyoma of the vulva. Cancer Genet Cytogenet. 2006 Oct 1. 170(1):58-60. [QxMD MEDLINE Link].
Guardiola MT, Dobin SM, Dal Cin P, Donner LR. Pericentric inversion (12)(p12q13-14) as the sole chromosomal abnormality in a leiomyoma of the vulva. Cancer Genet Cytogenet. 2010 May. 199 (1):21-3. [QxMD MEDLINE Link].
Alam NA, Bevan S, Churchman M, Barclay E, Barker K, Jaeger EE, et al. Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. Am J Hum Genet. 2001 May. 68(5):1264-9. [QxMD MEDLINE Link].
Alam NA, Olpin S, Rowan A, Kelsell D, Leigh IM, Tomlinson IP, et al. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. J Mol Diagn. 2005 Oct. 7(4):437-43. [QxMD MEDLINE Link].
Alam NA, Olpin S, Leigh IM. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol. 2005 Jul. 153(1):11-7. [QxMD MEDLINE Link].
Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, et al. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet. 2006 Jan. 43(1):18-27. [QxMD MEDLINE Link].
Badeloe S, van Geel M, van Steensel MA, Bastida J, Ferrando J, Steijlen PM, et al. Diffuse and segmental variants of cutaneous leiomyomatosis: novel mutations in the fumarate hydratase gene and review of the literature. Exp Dermatol. 2006 Sep. 15(9):735-41. [QxMD MEDLINE Link].
Breen KE, Carlo MI, Kemel Y, Maio A, Chen YB, Zhang L, et al. Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndrome. Mol Genet Genomic Med. 2020 Aug. 8 (8):e1293. [QxMD MEDLINE Link]. [Full Text].
Sánchez-Heras AB, Castillejo A, García D, Robledo M, Teulé A, Sánchez R, et al. Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization. Cancers (Basel). 2020 Nov 5. 12 (11):[QxMD MEDLINE Link]. [Full Text].
Seo JY, Ahn JY, Keam B, Kim M, Yoon S, Lee JL, et al. Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients. Ann Lab Med. 2021 Mar 1. 41 (2):207-213. [QxMD MEDLINE Link]. [Full Text].
Arenas Valencia C, Lopez Kleine L, Pinzon Velasco AM, Cardona Barreto AY, Arteaga Diaz CE. Gene expression analysis in peripheral blood cells of patients with hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC): identification of NRF2 pathway activation. Fam Cancer. 2018 Oct. 17 (4):587-599. [QxMD MEDLINE Link]. [Full Text].
Mitchum MD, Adams EG, Holcomb KZ. JAAD Grand Rounds quiz. A 46-year-old man with agminated papules on the buttock. Reed syndrome. J Am Acad Dermatol. 2012 Feb. 66 (2):337-9. [QxMD MEDLINE Link].
Shuch B, Li S, Risch H, Bindra RS, McGillivray PD, Gerstein M. Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer. Cancer. 2020 Aug 15. 126 (16):3657-3666. [QxMD MEDLINE Link].
Kuwada M, Chihara Y, Lou Y, Torimoto K, Kagebayashi Y, Tamura K, et al. Novel missense mutation in the FH gene in familial renal cell cancer patients lacking cutaneous leiomyomas. BMC Res Notes. 2014 Mar 31. 7:203. [QxMD MEDLINE Link].
Spies JB, Bradley LD, Guido R, Maxwell GL, Levine BA, Coyne K. Outcomes from leiomyoma therapies: comparison with normal controls. Obstet Gynecol. 2010 Sep. 116(3):641-52. [QxMD MEDLINE Link].
Kulkarni MR, Dutta I, Dutta DK. Clinicopathological Study of Uterine Leiomyomas: A Multicentric Study in Rural Population. J Obstet Gynaecol India. 2016 Oct. 66 (Suppl 1):412-6. [QxMD MEDLINE Link].
Ramesh P, Annapureddy SR, Khan F, Sutaria PD. Angioleiomyoma: a clinical, pathological and radiological review. Int J Clin Pract. 2004 Jun. 58(6):587-91. [QxMD MEDLINE Link].
Kamai T, Tomosugi N, Abe H, Kaji Y, Oyama T, Yoshida K. Protein profiling of blood samples from patients with hereditary leiomyomatosis and renal cell cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Int J Mol Sci. 2012 Nov 8. 13 (11):14518-32. [QxMD MEDLINE Link].
Szolomayer LK, Talusan PG, Chan WF, Lindskog DM. Leiomyoma of the Foot and Ankle: A Case Series. Foot Ankle Spec. 2016 Sep 20. [QxMD MEDLINE Link].
Woertler K. Soft tissue masses in the foot and ankle: characteristics on MR Imaging. Semin Musculoskelet Radiol. 2005 Sep. 9(3):227-42. [QxMD MEDLINE Link].
Ji X, Bi H, Dong A. Multiple Cutaneous Leiomyomas Showing Increased FDG Uptake. Clin Nucl Med. 2020 Oct. 45 (10):827-829. [QxMD MEDLINE Link].
Gunnala V1, Pereira N, Irani M, Lilienthal D, Pirog EC, Soslow R, et al. Multiple cutaneous leiomyomas leading to discovery of novel splice mutation in the fumarate hydratase gene associated with HLRCC. Australas J Dermatol. [QxMD MEDLINE Link].
Kilitci A, Elmas ÖF. Cutaneous Smooth Muscle Tumors: A Clinicopathological Study Focusing on the Under-Recognized Histological Features. Turk Patoloji Derg. 2020. 36 (2):126-134. [QxMD MEDLINE Link]. [Full Text].
Kishibe M, Igawa S, Kanno K, Matsuo R, Ishida-Yamamoto A. Inclusion bodies are not uncommon in angioleiomyoma. J Cutan Pathol. 2021 Feb. 48 (2):269-273. [QxMD MEDLINE Link].
Nakayama H, Enzan H, Miyazaki E, Kuroda N, Toi M. Lack of CD34 positive stromal cells within angiomyomas (vascular leiomyomas). J Clin Pathol. 2002 May. 55(5):395-6. [QxMD MEDLINE Link].
Fernandez-Flores A, Monteagudo C. Immunoexpression of p53 in cutaneous and subcutaneous leiomyosarcomas. Ann Diagn Pathol. 2016 Oct. 24:25-9. [QxMD MEDLINE Link].
Batchelor RJ, Lyon CC, Highet AS. Successful treatment of pain in two patients with cutaneous leiomyomata with the oral alpha-1 adrenoceptor antagonist, doxazosin. Br J Dermatol. 2004 Apr. 150(4):775-6. [QxMD MEDLINE Link].
Alam M, Rabinowitz AD, Engler DE. Gabapentin treatment of multiple piloleiomyoma-related pain. J Am Acad Dermatol. 2002 Feb. 46(2 Suppl Case Reports):S27-9. [QxMD MEDLINE Link].
Scheinfeld N. The role of gabapentin in treating diseases with cutaneous manifestations and pain. Int J Dermatol. 2003 Jun. 42(6):491-5. [QxMD MEDLINE Link].
Sifaki MK, Krueger-Krasagakis S, Koutsopoulos A, Evangelou GI, Tosca AD. Botulinum toxin type A--treatment of a patient with multiple cutaneous piloleiomyomas. Dermatology. 2009. 218(1):44-7. [QxMD MEDLINE Link].
Onder M, Adisen E. A new indication of botulinum toxin: leiomyoma-related pain. J Am Acad Dermatol. 2009 Feb. 60(2):325-8. [QxMD MEDLINE Link].
Malik K, Patel P, Chen J, Khachemoune A. Leiomyoma cutis: a focused review on presentation, management, and association with malignancy. Am J Clin Dermatol. 2015 Feb. 16 (1):35-46. [QxMD MEDLINE Link].
Choi Y, Keam B, Kim M, Yoon S, Kim D, Choi JG, et al. Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients. Cancer Res Treat. 2019 Oct. 51 (4):1549-1556. [QxMD MEDLINE Link]. [Full Text].
Wyvekens N, Valtcheva N, Mischo A, Helmchen B, Hermanns T, Choschzick M, et al. Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a tailored therapeutic approach. Genes Chromosomes Cancer. 2020 Nov. 59 (11):611-619. [QxMD MEDLINE Link].
Park I, Shim YS, Go H, Hong BS, Lee JL. Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures. BMC Urol. 2019 Jun 10. 19 (1):51. [QxMD MEDLINE Link]. [Full Text].
Gravvanis A, Kakagia D, Papadopoulos S, Tsoutsos D. Dermal skin template for the management of multiple cutaneous leiomyomas. J Cutan Med Surg. 2009 Mar-Apr. 13(2):102-5. [QxMD MEDLINE Link].
Chayed Z, Kristensen LK, Ousager LB, Rønlund K, Bygum A. Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review. Orphanet J Rare Dis. 2021 Jan 18. 16 (1):34. [QxMD MEDLINE Link]. [Full Text].
Pithukpakorn M, Toro JR, Pagon RA, Adam MP, Ardinger HH, Wallace SE, et al. Hereditary Leiomyomatosis and Renal Cell Cancer. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle. 1993. [QxMD MEDLINE Link]. [Full Text].
Skala SL, Dhanasekaran SM, Mehra R. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma. Arch Pathol Lab Med. 2018 Oct. 142 (10):1202-1215. [QxMD MEDLINE Link]. [Full Text].
Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittomäki K, Tomlinson I, et al. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer. 2014 Dec. 13 (4):637-44. [QxMD MEDLINE Link].
Baird DD, Hill MC, Schectman JM, Hollis BW. Vitamin d and the risk of uterine fibroids. Epidemiology. 2013 May. 24(3):447-53. [QxMD MEDLINE Link].